Literature DB >> 24760748

Home-made continuous positive airways pressure device may reduce mortality in neonates with respiratory distress in low-resource setting.

Subhashchandra Daga1, Sameer Mhatre2, Anushree Borhade2, Danish Khan2.   

Abstract

OBJECTIVE: To study the effectiveness of locally assembled low-cost version for continuous positive airway pressure (CPAP) delivery. PATIENTS: Babies with respiratory distress from two contiguous periods, one with CPAP therapy and the other without, were compared for following parameters: birth weight, gestational age, severity of respiratory distress, as assessed by Silverman-Anderson retraction score (SARS), maximum SARS, days taken for score to become 0, duration of oxygen therapy, hospital stay and the outcome.
RESULTS: The profile of subjects was comparable in two groups. Severity of respiratory distress (SARS) was significantly higher in post-CPAP group. Time taken for SARS to become 0 and number of deaths were significantly lower, and the duration of oxygen administration and hospital stay were significantly higher in post-CPAP group. The cost of an individual disposable CPAP unit was ∼Rs 160 (USD 3).
CONCLUSION: A low-cost and locally assembled CPAP delivery system may reduce neonatal mortality among babies with respiratory distress.
© The Author [2014]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24760748     DOI: 10.1093/tropej/fmu023

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

1.  Nonclinical Bench Performance Testing of a Very Low-Cost Nonelectric Bubble Continuous Positive Airway Pressure (bCPAP) and Blenders Device Designed for Newborn Respiratory Support.

Authors:  Patricia S Coffey; Alec Wollen
Journal:  Med Devices (Auckl)       Date:  2022-06-27

2.  Reducing preterm mortality in eastern Uganda: the impact of introducing low-cost bubble CPAP on neonates <1500 g.

Authors:  F Okello; E Egiru; J Ikiror; L Acom; Ksm Loe; P Olupot-Olupot; K Burgoine
Journal:  BMC Pediatr       Date:  2019-09-04       Impact factor: 2.125

Review 3.  Continuous positive airway pressure in managing acute respiratory distress in children in district hospitals: evidence for scale-up.

Authors:  Frank Baiden; Patrick T Wilson
Journal:  Ghana Med J       Date:  2021-09

4.  Effectiveness of Bubble Continuous Positive Airway Pressure (BCPAP) for Treatment of Children Aged 1-59 Months with Severe Pneumonia and Hypoxemia in Ethiopia: A Pragmatic Cluster Randomized Controlled Clinical Trial.

Authors:  Meseret Gebre; Kassa Haile; Trevor Duke; Md Tanveer Faruk; Mehnaz Kamal; Md Farhad Kabir; Md Fakhar Uddin; Muluye Shimelis; Bethelhem Solomon; Abebe Genetu Bayih; Alemseged Abdissa; Taye Tolera Balcha; Rahel Argaw; Asrat Demtse; Abate Yeshidenber; Abayneh Girma; Bitseat W Haile; Tahmeed Ahmed; John D Clemens; Mohammod Jobayer Chisti
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

5.  Availability and use of continuous positive airway pressure (CPAP) for neonatal care in public health facilities in India: a cross-sectional cluster survey.

Authors:  Juan Emmanuel Dewez; Sushma Nangia; Harish Chellani; Sarah White; Matthews Mathai; Nynke van den Broek
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692

6.  Implementing bubble continuous positive airway pressure in a lower middle-income country: a Nigerian experience.

Authors:  Chiamaka Aneji; Tyler Hartman; Oluyinka Olutunde; Ikechukwu Okonkwo; Eghosa Ewumwen; Oniyire Adetiloye; Joseph de Graft-Johnson; Chinyere Ezeaka; Angela Okolo; Ngozi Ibeziako; Obumneme Ezeanosike; Patricia Medupin; George Little
Journal:  Pan Afr Med J       Date:  2020-09-03

Review 7.  Feasibility of Pediatric Non-Invasive Respiratory Support in Low- and Middle-Income Countries.

Authors:  Krishna Mohan Gulla; Sushil Kumar Kabra; Rakesh Lodha
Journal:  Indian Pediatr       Date:  2021-05-03       Impact factor: 1.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.